Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.

Atherosclerosis - 1 May 2015

Haralambos K, Whatley S D, Edwards R, Gingell R, Townsend D, Ashfield-Watt P, Lansberg P, Datta D B N, McDowell I F W

Abstract excerpt

BACKGROUND/OBJECTIVE: Familial Hypercholesterolaemia (FH) is caused by mutations in genes of the Low Density Lipoprotein (LDL) receptor pathway. A definitive diagnosis of FH can be made by the demonstration of a pathogenic mutation. The Wales FH service has developed scoring criteria to guide sel...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticholesteremic Agents
Share to Apolipoprotein B-100
Share to Hyperlipidemia, Familial Combined

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hyperlipoproteinemia Type II

Share to Patient Selection

Share to Proprotein Convertase 9

Share to Proprotein Convertases

Source

Identifiers

PMID: 25797312
DOI: 10.1016/j.atherosclerosis.2015.03.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25797312-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.PMID 25797312Read ↗

Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemiaSemantic proximity Read ↗

The genetics and screening of familial hypercholesterolaemiaSemantic proximity Read ↗

Genetic analysis of familial hypercholesterolaemia in Western Australia.Semantic proximity Read ↗

Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic.Semantic proximity Read ↗

What is the clinical utility of DNA testing in patients with familial hypercholesterolaemia?Semantic proximity Read ↗

Selection of individuals for genetic testing for familial hypercholesterolaemia: development and external validation of a prediction model for the presence of a mutation causing familial hypercholesterolaemia.Semantic proximity Read ↗

Genetic testing for a patient with suspected familial hypercholesterolaemia.Semantic proximity Read ↗

Familial hypercholesterolaemia: a pressing issue for European health care.Semantic proximity Read ↗

A Scoping Review of Approaches for the Detection and Management of Familial Hypercholesterolaemia in Primary CareSemantic proximity Read ↗

Genetic diagnosis of familial hypercholesterolaemia using a rapid biochip array assay for 40 common LDLR, APOB and PCSK9 mutations.Semantic proximity Read ↗

Genetic testing for familial hypercholesterolaemia: practical and ethical issues.Semantic proximity Read ↗

A service evaluation: impact of nurse-led regional familial hypercholesterolaemia service on a hospital adult lipid clinicSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.